Neurosciences
Neuroinflammation in the Genesis of Epilepsy
Feb 2025
Fast Track Article
Journal Title:
Current Psychopharmacology
Epilepsy is the second most typical chronic disorder described by recurrent seizures and uncontrolled electrical signaling from neurons in the cerebral cortex. Stimulated astrocytes along with microglia promote cytokines that cause neuroinflammation leading to a chain reaction of subsequent steps involving neurons as well as endothelial cells along the blood-brain barrier. Inflammation in the brain’s neural network can cause convulsions and epilepsy. T Read More
Advancing Alzheimer's Treatment: Unleashing the Power of Donanemab and Quantum Computing for Enhanced Patient Outcomes
Jan 2025
Fast Track Article
Journal Title:
Current Psychopharmacology
Donanemab is the first antibody to target pyroglutamate-modified amyloid-beta in Alzheimer's disease selectively; thus it represents a significant breakthrough in disease-modifying treatments. Importantly its mechanism of action encourages adequate clearance of plaques and does not even worsen outcomes for early-stage patients in contrast to previous treatments that did not promote clearing for plaques or even worsened the outcomes of Read More
Potential of Andrographolide and Andrographis paniculata Extracts for the Management of Diabetes-associated Psychopathologies: Current Status
Dec 2024
Fast Track Article
Journal Title:
Current Psychopharmacology
Despite the availability of numerous anti-hyperglycemic and psychoactive drugs and diverse therapeutic modalities prevention and cure of diabetes-associated mental health problems continue to be a major challenge for medical practitioners. Considerable efforts have been made in many research laboratories including ours to identify the bioactive of traditionally known medicinal or food plants to identify their bioactive that could be used for Read More
Metaforest Algorithm Insights: Predictors of Nocebo Response in ADHD
Dec 2024
Fast Track Article
Journal Title:
Current Psychopharmacology
Background Predicting the nocebo response in randomized controlled trials (RCTs) is crucial as it can help minimize its influence and improve the evaluation of the side effects of interventions for ADHD. The aim of this study is to determine the effect of covariates related to study design intervention and patients’ characteristics on the nocebo response in patients with Attention Deficit Hyperactivity Disorder (ADHD) using Metaforest and ultimately to investig Read More
Marine Natural Products as Novel Treatments for Alzheimer's Disease
Dec 2024
Fast Track Article
Journal Title:
Current Psychopharmacology
Alzheimer's disease is distinguished by gradual changes in behavior because of the aggregation of β-amyloid and τ protein that blocks the signal transduction pathway. It is one of the major problems in the current scenario. It mainly occurs after the age of 60 and eventually leads to memory loss. Nonetheless medicinal plants have therapeutic potential to improve many diseases. Medicinal drugs with their phytoconstituents may offer therapeutic potenti Read More
The Brain: A Systems Neuroscience Perspective
Oct 2024
Book
The Brain: A Systems Neuroscience Perspective is a comprehensive textbook designed for undergraduate students in neuroscience. It offers a detailed exploration of brain dynamics spatial navigation and the neuroscience of Alzheimer's disease with an emphasis on understanding complex concepts through simplified mathematical models. The objective is to provide a solid foundation for readers in systems neuroscience.Key TopicsFundamental Brain D Read More
Thyroid and Brain: Understanding the Actions of Thyroid Hormones in Brain Development and Function
Sep 2024
Book
This comprehensive textbook offers an in-depth exploration of how thyroid hormones influence brain development and function particularly on cellular and molecular mechanisms. Readers will find current insights into the complex interplay between the thyroid and neurological systems making it a valuable resource for researchers advanced learners and clinicians in the fields of endocrinology neuroscience and developmental biology.The book starts Read More
A Literature-Based Study of Tardive Dyskinesia- From Pathogenesis to Treatment
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E22115560304943
(2024)
Tardive dyskinesia (TD) is induced by antipsychotic drugs that have dopamine-antagonising properties. It frequently causes physical and mental anguish in individuals lowering their quality of life. Recent research on the aetiology and pathogenesis of TD indicates that genetic predisposition treatment options age sex and lifestyle factors are among the key risk factors contributing to the development of TD. Various genetic polymorphisms along with severe o Read More
The Present Difficulties and Potential Benefits of Dopaminergic Agents in Parkinson's Disease Treatment
Jan 2024
Article
Source:
Current Psychopharmacology
12,
e22115560332182
(2024)
Parkinson's disease (PD) is a progressive neurological condition characterized by bradykinesia rigidity tremors and impaired balance among other motor impairments. The issue arises from dopaminergic neurons located in the spinal column of the brain. This research report examines the therapeutic potential of dopaminergic medications in the management of Parkinson's disease. The central concept of Parkinson's disease (PD) revolves around the noti Read More
Positive Psychotic Symptoms after Escitalopram Treatment in a Female Adolescent with Peroxisome Spectrum Disorder Due to PEX-6 Gene Mutation
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E22115560310023
(2024)
IntroductionIn this case report we present positive psychotic symptoms that developed after low-dose (5 mg/day) escitalopram treatment in a 16-year-old female adolescent with a peroxisome biogenesis disorder.Case presentationTwo weeks after starting escitalopram treatment for depression the patient experienced vomiting attacks several times a day. About 2-3 days after the attacks began the family stopped administering escitalopram. Five day Read More
The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E190124225864
(2024)
Depression has a high prevalence and associated comorbidities. It is still unknown what the molecular basis of depression is regardless of many theories that have been put up to explain it. Many researchers investigate that present-day therapies for depression are ineffective due to their low efficacy delayed onset of action (typically two weeks) and adverse effects. Novel medications that operate more quickly and effectively are thus needed. Several novel m Read More
A Comprehensive Review on the Neuropharmacological Effects of Antidepressants in Various Prospects
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E070723218522
(2024)
Depression is one of the most challenging diseases for society to treat. It is a highly prevalent and disabling illness in the general population. Affective disorders are characterised by depressed mood diminished interest and pleasure feelings of guilt or poor self-worth sleep or food difficulties decreased energy and impaired attention. This manuscript will look at depression from a behavioural analytic perspective. The pathogenesis of major depres Read More
Hippocampal Serotonin and Responses to Immobilization Stress in Rats Treated with Metformin
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E290424229519
(2024)
BackgroundStress-related illnesses and depression are rising in modern society. Selective serotonin reuptake inhibitors as well as other antidepressants are also not very effective and commonly exhibit partial remission suggesting the need for novel therapeutic agents for treating anxiety and depression.ObjectiveThe present study was designed to investigate serotonergic mechanisms in the potential anxiolytic and stress-reducing effect Read More
The Neurochemical Anatomy of Runway Acquisition and Extinction
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E301223225099
(2024)
A review is presented as to the neurochemical basis of the straight runway task usually consisting of an acquisition phase followed by an extinction phase. During the acquisition of the appetitive runway task running speeds from the start box to the goal box progressively increase over trials and then decrease when the reward is withheld. Runway extinction is susceptible to lesions of the limbic system including the medial frontal cortex the hippocampus t Read More
Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E030724231519
(2024)
BackgroundFollowing clinical trials on psilocybin for the treatment of pain anxiety and depression in patients with cancer scientific interest emerged in its use for substance use disorders.MethodsIn this review of the literature we summarize available trials looking at the use of psilocybin in addiction.ResultsOne double-blind randomized clinical trial looked at the effect of psilocybin on heavy drinking in adults diagnosed with alcohol dependence. Several trial Read More
Semaglutide’s Neuropharmacological Effects: From Glycemic Regulation and Weight Loss to Potential Implications in Substance Use Disorders – A Narrative Review
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E301223225100
(2024)
This narrative review delves into the potential therapeutic implications of semaglutide a Glucagon-Like Peptide-1 (GLP-1) receptor agonist in the context of Substance Use Disorders (SUDs). By systematically exploring databases from 2011 to 2023 and incorporating foundational works from 2004 a total of 59 articles were identified as pertinent to the topic. Utilizing the SANRA scale for assessment the quality and relevance of these studies were rigorousl Read More
Rapid Metabolism of Monthly Extended-Release Buprenorphine Formulation: A Case Report
Jan 2024
Article
Source:
Current Psychopharmacology
12,
E310524230588
(2024)
BackgroundMedication-assisted treatment constitutes the gold standard management for patients with opioid use disorder. Many factors can alter the response to medications including genetic variations. In this case report we discuss the presentation of a patient maintained on subcutaneous extended-release buprenorphine formulation who repeatedly presented objective and subjective signs of opioid withdrawal when he was switched from wee Read More
Current Psychopharmacology
ISSN: 2211-5560
E-ISSN: 2211-5579
Journal
Current Psychopharmacology publishes peer-reviewed expert review articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology. Data must be published for the first time in Current Psycho Read More
No more items...